Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
39,276,318
-
Share change
-
+3,013,749
-
Total reported value
-
$47,914,188
-
Put/Call ratio
-
64%
-
Price per share
-
$1.22
-
Number of holders
-
81
-
Value change
-
+$590,085
-
Number of buys
-
52
-
Number of sells
-
30
Institutional Holders of TRANSENTERIX INC - COM NEW (TRXC) as of Q2 2016
As of 30 Jun 2016 TRANSENTERIX INC - COM NEW (TRXC) had 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 39,276,318 shares of stock of the company.
Largest 10 holders included Aisling Capital LLC, SV Life Sciences Advisers, LLC, JPMORGAN CHASE & CO, StepStone Group LP, AQR CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, MASTERS CAPITAL MANAGEMENT LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., and NORTHERN TRUST CORP.
This table shows 81 institutional shareholders of the security as of 30 Jun 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.